Bernard Tobin previously held several senior positions at Amgen, including Executive Director of National Accounts, General Manager of both the Netherlands and Brazil, and Global Head of Commercial Excellence. In addition, he led the global integration of a business development acquisition in more than 100 countries. Prior to that, Mr. Tobin held a variety of leadership roles in the commercial organization at Eli Lilly and Co. He received his B.S. degree in public service and administration from Iowa State University and his M.B.A. from the Fuqua School of Business, Duke University.
Elena Hitraya, M.D., Ph.D.Chief Medical Officer
Dr. Hitraya joined Crescendo in 2015. She comes to the Company with more than 25 years of experience in rheumatology and immunology, and has published extensively. Over the past 11 years, Dr. Hitraya has held several leadership positions at Genentech, including most recently as group medical director of rheumatology/immunology for the Genentech/Roche group. Prior to Genentech, she was regional director of medical affairs for immunology at Centocor, a division of Johnson & Johnson. Dr. Hitraya received her medical degree from Semmelweis Medical University, Budapest, Hungary and her doctoral degree in clinical rheumatology from the Institute of Rheumatology of the Russian Academy of Medical Sciences, Moscow, Russia. She completed a postdoctoral fellowship in molecular biology at the Division of Rheumatology at Thomas Jefferson University, Philadelphia, PA.
David Chernoff, MDSenior Vice President, Medical Affairs
Dr. Chernoff has served as acting Chief Medical Officer for several start-up molecular diagnostic companies including XDx, CardioDx, and Tethys Bioscience. Previously, he was Vice President of Corporate Technology at Elan Pharmaceuticals and Medical Director of Chiron Diagnostics, where he played a pivotal role in the development of assays for HIV, HCV, HBV, and CMV. He recently spent two years as an Entrepreneur-in-Residence and one year as an Operating Partner at the venture firm TPG. Dr. Chernoff holds an MD from New York University and completed his medical training in internal medicine, rheumatology, and infectious disease at the University of California, San Francisco.
Robert HillVice President, Sales and Marketing
Mr. Hill joined Crescendo in 2017 to lead the sales and marketing organization. Prior to joining Crescendo Bioscience, Mr. Hill was the Senior Director of Managed Markets at Myriad Genetics, Inc. (Crescendo’s parent company). He joined Myriad in 2009 where he held leadership positions in both sales and marketing. Mr. Hill was instrumental in developing and implementing strategies to increase hereditary cancer volumes and expanded the reach and focus of the sales force. He is a LEAN expert and applies his knowledge toward continuous improvement for patient care. Prior to working at Myriad, Mr. Hill worked at Eli Lilly and Company in roles in sales, operations, and marketing. He received a BS in Cell and Molecular Biology and a Master of Business Administration from Oklahoma State University.
William C. Manning, Jr., Ph.D.Vice President, Lab Operations
Dr. Manning joined Crescendo Bioscience in February 2009 and was involved in the development and analytical validation of Vectra DA. He is currently responsible for operations in the commercial clinical lab, the research and development lab, and manufacturing. He came to Crescendo from Genentech, where for 5 years he was Associate Director, Biomarkers in early clinical development for immunology and oncology. Prior to joining Genentech in 2004, he was Associate Director of Translational Medicine at Sugen, Inc. Before Sugen, Dr. Manning spent 7 years at Chiron Corporation working in gene therapy and vaccine research. Dr. Manning earned a B.S. in Genetics at Purdue University and a Ph.D. in Molecular Virology at Stanford University.
Kathleen McKusickVice President, Technology
Ms. McKusick is responsible for software engineering and information technology at Crescendo Bioscience. She joined Crescendo Bioscience in 2009 and led the development of software and data systems in support of the launch of Vectra DA in our commercial clinical lab. In 2011 her responsibilities were expanded to include management of Crescendo's externally facing tools and commercial software. Ms. McKusick oversaw technical development of Crescendo's LIMS, physician and customer portals, data warehouse and strategic reporting tools, and Crescendo’s app, MyRA®. Ms. McKusick began her technical career supporting AI research at NASA Ames and then joined the Human Genome Project at Stanford where she managed a team building LIMS systems and developing early mapping algorithms. She held Software Engineering management positions at several startups before joining Crescendo. Ms. McKusick holds an AB degree in Biology from Brown University and a MS degree in Computer Science from Vanderbilt University.
Eric Sasso, MDVice President, Medical and Scientific Affairs
Dr. Sasso joined Crescendo Bioscience in September 2012. He came to Crescendo from Abbott Laboratories, where as Medical Director, he worked in Early Immunology clinical development and in Humira Medical Affairs, both in Rheumatology and as head of the global Dermatology team. Prior to joining Abbott, he was an Associate Professor at the University of Washington, Seattle, where he is currently an Affiliate Professor. Dr. Sasso earned an A.B. Biochemistry degree at Harvard University, Cambridge, MA, and an M.D. degree from the University of California, San Diego. He trained in internal medicine at McGill University, Montreal, rheumatology at the University of Washington and immunology research at the Virginia Mason Research Center, Seattle. He is board certified in Internal Medicine and Rheumatology and has published extensively in the fields of rheumatology, immunology and dermatology.